Artelo Biosciences CEO to Speak at Major Healthcare Event
Artelo Biosciences, Inc. (Nasdaq: ARTL), a forward-thinking pharmaceutical company located in Solana Beach, California, focuses on innovative treatments targeting lipid-signaling pathways for a variety of health conditions. The company is at the forefront of developing therapeutic solutions for patients suffering from cancer, chronic pain, and other serious disorders.
Scheduled for October 15-17, 2024, the Maxim Group 2024 Virtual Healthcare Summit is an excellent platform for engaging dialogue and discovery in the healthcare sector. Gregory D. Gorgas, CEO of Artelo Biosciences, will engage in a fireside chat alongside Jason McCarthy, Senior Managing Director and Head of Biotechnology Research at Maxim Group.
Event Focus and Engagement
On October 16, 2024, at 4:00 PM ET, Gorgas will discuss critical insights regarding Artelo's pioneering treatments and their developments aimed at addressing significant unmet medical needs across various disease states. This interactive session signifies the company's commitment to transparency and innovation in the biopharmaceutical space.
Participants can join this enlightening session by registering in advance, allowing them to gain firsthand knowledge about the evolving landscape of oncology and pain management therapies. Artelo’s approach not only highlights their scientific advancements but also emphasizes their strategies for regulatory compliance and market introduction.
Company Overview
Artelo Biosciences is dedicated to commercializing proprietary therapeutic products designed specifically to modulate lipid-signaling pathways. Their mission is to address crucial gaps in treatments for conditions such as anorexia, anxiety, pain, inflammation, and skin disorders. Led by a team of seasoned biopharmaceutical experts, Artelo is advancing its promising pipeline with a blend of robust scientific rigor and innovative approaches.
The company collaborates closely with respected researchers and technology specialists to ensure that their products are backed by solid and cutting-edge scientific research. Their commitment to delivering impactful therapies is evident in their thorough development process, ensuring that they meet the needs of healthcare providers and patients alike.
Contact Information
For those interested in learning more about Artelo Biosciences and their initiatives, Crescendo Communications handles investor relations. Interested parties can get in touch by phone at 212-671-1020 or by email at ARTL@crescendo-ir.com. This support offers insight into the company’s vision and ongoing projects.
Frequently Asked Questions
What is the focus of Artelo Biosciences?
Artelo Biosciences specializes in developing treatments that modulate lipid-signaling pathways to combat various serious health conditions, including cancer and pain.
When will the fireside chat take place?
The chat is scheduled for October 16, 2024, at 4:00 PM ET during the Maxim Group Virtual Healthcare Summit.
How can one register for the event?
Participants can register online to gain access to the webcast of the fireside chat featuring Gregory D. Gorgas.
What are some diseases Artelo aims to address?
Artelo has a strong focus on conditions like cancer, anxiety, pain, anorexia, and dermatological issues.
Who should attend the Maxim Group Virtual Healthcare Summit?
This event is ideal for investors, healthcare professionals, and anyone interested in innovations in pharmaceuticals and healthcare advancements.
